[Antley-Bixler syndrome or POR deficiency?]
- PMID: 18630181
[Antley-Bixler syndrome or POR deficiency?]
Abstract
Antley-Bixler syndrome (ABS) is a rare congenital disorder characterized by numerous craniofacial, skeletal and, in some cases, urogenital abnormalities resulting from disordered steroidogenesis. Known genetic causes in sporadic cases of ABS include dominant mutations in the fibroblast growth factor 2 receptor gene (FGFR2). Recent research shows surprisingly that symptoms of Antley-Bixler syndrome, combined with disordered steroidogenesis and urogenital anomalies, are caused by mutations in the POR gene that encodes NADPH-cytochrome P450 oxidoreductase (CYPOR). CYPOR is a four domain-containing monomeric flavoprotein that contains two flavins, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), a binding site for NADPH, and the N-terminal sequence of 25 amino acids which determines the microsomal localization of the protein. CYPOR is the electron donor to microsomally localized cytochromes P450 that participate in xenobiotic metabolism and steroidogenesis. Mutations in the POR gene lead to apparent diminished activity of some P450 enzymes. Association of CYPOR with ABS discloses new facts about this disease and recent research shows that patients with ABS-like skeletal anomalies, but with mutations in the POR gene and disordered steroidogenesis, represent a new disorder called POR deficiency.
Similar articles
-
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome.Nat Genet. 2004 Mar;36(3):228-30. doi: 10.1038/ng1300. Epub 2004 Feb 1. Nat Genet. 2004. PMID: 14758361
-
Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.J Biol Chem. 2006 Nov 24;281(47):35975-82. doi: 10.1074/jbc.M607095200. Epub 2006 Sep 24. J Biol Chem. 2006. PMID: 16998238
-
Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.Fundam Clin Pharmacol. 2007 Aug;21(4):399-410. doi: 10.1111/j.1472-8206.2007.00520.x. Fundam Clin Pharmacol. 2007. PMID: 17635179 Review.
-
P450 oxidoreductase deficiency: a new disorder of steroidogenesis.Ann N Y Acad Sci. 2005 Dec;1061:100-8. doi: 10.1196/annals.1336.012. Ann N Y Acad Sci. 2005. PMID: 16467261 Review.
-
Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.Am J Hum Genet. 2005 May;76(5):729-49. doi: 10.1086/429417. Epub 2005 Mar 25. Am J Hum Genet. 2005. PMID: 15793702 Free PMC article.
Cited by
-
Exploring Novel Variants of the Cytochrome P450 Reductase Gene (POR) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays.Biomolecules. 2023 Nov 30;13(12):1728. doi: 10.3390/biom13121728. Biomolecules. 2023. PMID: 38136599 Free PMC article.
-
Antley-Bixler syndrome arising from compound heterozygotes in the P450 oxidoreductase gene: a case report.Transl Pediatr. 2021 Dec;10(12):3309-3318. doi: 10.21037/tp-21-499. Transl Pediatr. 2021. PMID: 35070845 Free PMC article.
-
NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family.Arch Biochem Biophys. 2012 Dec 1;528(1):72-89. doi: 10.1016/j.abb.2012.09.002. Epub 2012 Sep 11. Arch Biochem Biophys. 2012. PMID: 22982532 Free PMC article. Review.
-
A gas chromatography-mass spectrometry-based whole-cell screening assay for target identification in distal cholesterol biosynthesis.Nat Protoc. 2019 Aug;14(8):2546-2570. doi: 10.1038/s41596-019-0193-z. Epub 2019 Jul 24. Nat Protoc. 2019. PMID: 31341291
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous